GUO Lei, FENG Dong-ze, ZHANG Bao-chao, et al. Influence Shuxue Tong Injection to Patients' Blood Lipid in Treating Acute Cerebral Infarction and Its' Mechanism of Action[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(14): 197-200.
DOI:
GUO Lei, FENG Dong-ze, ZHANG Bao-chao, et al. Influence Shuxue Tong Injection to Patients' Blood Lipid in Treating Acute Cerebral Infarction and Its' Mechanism of Action[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(14): 197-200. DOI: 10.13422/j.cnki.syfjx.2014140197.
Influence Shuxue Tong Injection to Patients' Blood Lipid in Treating Acute Cerebral Infarction and Its' Mechanism of Action
Objective: Discuss intervention effect of Shuxue Tong injection to patients' blood lipid in treating acute cerebral infarction and influence to serum high sensitivity C-reactive protein(hs-CRP)
adiponectin(APN)
oxidized low-density lipoprotein(ox-LDL) and tumor necrosis factor-α(TNF-α). Method: Sixty-seven patients were randomly divided into control group (22 cases) and observation group (45 cases)by random number table.Patients in the control group received conventional western medicine treatment
and atorvastatin calcium tablets were used as medicine of reducing lipid
10 mg/time
1 time/day
taken orally after dinner.Based on the treatment of control group
patients in the observation group added Shuxue Tong injection
6 mL/time
intravenous infusion
1 time/day
course of treatment were 14 days.On day 0 and at the seventh and fourteenth day after treatment
severity of neurological impairment was evaluated by National Institute of Health Stroke Scale(NIHSS) scale.Triglyceride(TG)
level of total cholesterol(TC)
high-density lipoprotein(HDL-C) and low density lipoprotein(LDL-C) were detected.hs-CRP was detected by enzyme linked immunosorbent assay.APN
ox-LDL and TNF-α were detected.Before and after treatment
hemorheology was detected. Result: At the seventh day after treatment
compared with the time before treatment
scores of NIHSS in two groups decreased(P<0.01)
which meant no statistical significance from the differences between two groups.At the fourteenth day after treatment
scores of NIHSS in two groups kept decreasing(P<0.01)
and score of NIHSS in observation group was lower than in control group(P<0.01).Compared with the time before treatment
levels of serum hs-CRP
ox-LDL and TNF-α decreased(P<0.01)
and which in observation group were lower than those in control group(P<0.01).Compared with the time before treatment
levels of serum APN in two groups increased(P<0.01)
and which in observation group was higher than in control group(P<0.01).Levels of TC
TG and LDL-C in two groups decreased obviously(P<0.01)
and levels of TC and TG in observation group were lower than those in control group(P<0.01).Levels of HDL-C in two groups increased(P<0.01)
and there was no statistical significance from the differences between two groups.Amelioration of whole blood viscosity
aggregation rate of platelet
plasma viscosity and hematokrit in observation group was superior to those in control group(P<0.01). Conclusion: Shuxue Tong injection can ameliorate patients' neurological function in treating acute cerebral infarction and patients' lipid metabolism
and it has functions of anti-inflammatory
antioxidant and ameliorating cerebral microcirculation.
Effect of Tongnaoyin on Cerebral Hemodynamics in Patients with Acute Cerebral Infarction of Phlegm and Blood Stasis Syndrome Based on CTA/CTP
Evaluation of GRADE Clinical Research Evidence of Chinese Patent Medicine Combined with Western Medicine in Treatment of Hypertension with Dyslipidemia
Comparison on Rat Models of Acute Cerebral Infarction Due to Stasis Combined with Toxin Complicated with Cerebral-cardiac Syndrome
Buyang Huanwutang Alleviates Inflammatory Injury After Cerebral Ischemia-reperfusion in Rats via Activating Adiponectin Pathway
Clinical Effect of Erchentang and Bixie Fenqingyin Combined on Patients with Acute Cerebral Infarction with Hyperuricemia with Syndrome of Phlegm and Blood Stasis Blocking Collaterals
Related Author
JI Lianhong
LIU Peian
LI Li
LI Yunze
ZHU Qing
TANG Xiaogang
JIANG Hui
LIU Yongkang
Related Institution
The Affiliated Hospital of Nanjing University of Chinese Medicine/ Jiangsu Province Hospital of Chinese Medicine
Dongzhimen Hospital, Beijing University of Chinese Medicine
Shaanxi University of Chinese Medicine
Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences
Xiyuan Hospital, China Academy of Chinese Medical Sciences